Exits aren't hard to find when you know where to look
The overall exit market for startups has suffered in recent years, and life science and healthcare have not bucked the trend. M&A deals have slowed across the board as potential buyers balked at inflated valuations. While there are signs that the IPO market is recovering—with some successful high-profile IPOs from Hinge Health and BillionToOne,—funds have struggled to convert investments back into liquidity, slowing the reinvestment feedback loop that venture capital relies on.
Women's health has drawn criticism for a lack of exits, with investors wondering whether the sector is simply facing the same market headwinds as the rest of the innovation ecosystem or if there are serious structural issues holding them back. There has been some acquisition activity in the space, but unicorns like Maven Clinic, Flo and Bellabeat show no immediate interest in an IPO or exit. As the definition of women's health expands, the set of comparable exits grows. The successful IPOs of Hinge Health and BillionToOne show that companies that include women's health in their portfolio or focus on conditions that disproportionately affect women can achieve blockbuster exits.
Private equity is also playing a larger role in the exit market. The pending acquisition of Hologic by Blackstone and TPG offers insight into how the market values women's health. Hologic, while not explicitly a women's health company, features diagnostics and devices fundamental to women's healthcare. In fact, the deal includes about $700 million in contingent payments tied to the revenue of the Hologic breast health business. The deal signals a vision of women's health diagnostics and imaging as a core component of healthcare strategy, one with recurring, protected revenue, strong margins and room for operational improvement. Not coincidentally, these technologies also produce immense proprietary datasets with a value that's only increasing.
Women's health sits at the crossroads of several transformative healthcare innovation trends: integrated care, precision medicine, shared decision-making and new revenue models. These shifts have been moving from the periphery of healthcare toward the mainstream for years but have yet to gain broad traction in traditional care settings.
Patients and consumers today are looking for more convenience, more accessibility and more personalized care. They're increasingly demanding providers who understand and address their specific concerns and needs. Women—who have endured a lifetime with a healthcare system that discounts their concerns, routinely misdiagnoses their conditions, and treats male biology as the default—are leading this charge. Startups like Visana Health are delivering integrated whole-body care tailored to women's needs and conditions, combining testing, primary and specialty care, and longitudinal coaching.
From midlife care to longevity: The new care models
Personalized, multisystem care for menopause and perimenopause is improving both immediate and long-term health outcomes. Studies have shown such care helps women preserve muscle mass and bone density in midlife; helps prevent cognitive and sensory decline; and delivers statistically significant improvements in reported quality of life, memory and attention.
Midi Health, which raised $150 million across two rounds in 2025, is an example of this approach. Without changing its target demographic—women in midlife—it started offering care for metabolic diseases, obesity, and broader hormonal health, with a stronger focus on preventive healthcare. It began tracking its impact on a variety of clinical metrics and marketing its clinical and financial ROI to payers and employers. Essentially, Midi adopted a broad, longitudinal care model focused on the breadth of a patient's needs, not just a single condition.
Similar transitions have been a struggle in the traditional healthcare system, where the shift from FFS reimbursement to value-based contracts has been going on for decades. Even alternative and virtual care startups have bowed to the necessities of billing. Women's health companies are showing the rest of the healthcare industry how to build integrated care models aligned with the long-term health focus that value-based payments encourage.